688131.SHG Shanghai Haoyuan Chemexpress Co. Ltd. A

Healthcare Pharmaceuticals Shanghai Stock Exchange
100.80 CNY
Close of Nov 4, 2026
59.52 111.30
Market cap
CNY 21.5B
P/E
61.5x
P/B
5.58x
ROE
12.0%
Dividend yield
0.36%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 688131.SHG undervalued?

Graham number

The Graham number of Shanghai Haoyuan Chemexpress Co. Ltd. A cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shanghai Haoyuan Chemexpress Co. Ltd. A fundamental analysis

No fundamental analysis for Shanghai Haoyuan Chemexpress Co. Ltd. A yet.

Shanghai Haoyuan Chemexpress Co. Ltd. A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shanghai Haoyuan Chemexpress Co. Ltd. A

Shanghai Haoyuan Chemexpress Co., Ltd. engages in the research, development, and manufacture of pharmaceutical intermediates and small molecule drugs. It offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

Full company profile